Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Author:
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.nature.com/articles/nrd3800.pdf
Reference218 articles.
1. Dinarello, C. A. Biological basis for interleukin-1 in disease. Blood 87, 2095–2147 (1996).
2. Dinarello, C. A. Anti-inflammatory agents: present and future. Cell 140, 935–950 (2010).
3. Vojinovic, J. et al. Safety and efficacy of an oral histone deacetylase inhibitor in systemic onset juvenile idiopathic arthritis. Arthritis Rheum. 63, 1452–1458 (2011).
4. Goldbach-Mansky, R. Current status of understanding the pathogenesis and management of patients with NOMID/CINCA. Curr. Rheumatol. Rep. 13, 123–131 (2011).
5. Larsen, C. M. et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356, 1517–1526 (2007). This study opens the door to the concept that type 2 diabetes is an inflammatory disease that is primarily mediated by IL-1β.
Cited by 1472 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Igniting hope: Harnessing NLRP3 inflammasome-GSDMD-mediated pyroptosis for cancer immunotherapy;Life Sciences;2024-10
2. 13,14-seco withaphysalins from Physalis minima and their inhibitory effects on NLRP3 inflammasome activation;Bioorganic Chemistry;2024-10
3. Comparison of Morphine and Endomorphin Analog ZH853 for Tolerance and Immunomodulation in a Rat Model of Neuropathic Pain;The Journal of Pain;2024-10
4. An exploratory analysis of associations of genetic variation with the efficacy of tocilizumab in severe COVID-19 patients. A pharmacogenetic study based on next-generation sequencing;Frontiers in Pharmacology;2024-09-13
5. Elastin-specific MR probe for visualization and evaluation of an interleukin-1β targeted therapy for atherosclerosis;Scientific Reports;2024-09-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3